Source:http://linkedlifedata.com/resource/pubmed/id/18403104
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2008-6-10
|
pubmed:abstractText |
The human endometrium is a dynamic remodeling tissue undergoing more than 400 cycles of regeneration, differentiation and shedding during a woman's reproductive years. The co-ordinated and sequential actions of estrogen and progesterone direct these major remodeling events preparing a receptive endometrium for blastocyst implantation on a monthly basis. Adult stem/progenitor cells are likely responsible for endometrial regeneration. Functional approaches have been used to identify candidate endometrial stem/progenitor cells, as there are no specific stem cell markers. Rare populations of human endometrial epithelial and stromal colony-forming cells/units (CFU) and side population (SP) cells have been identified. Several growth factors are required for CFU activity: epidermal growth factor (EGF), transforming growth factor alpha (TGFalpha) and platelet-derived growth factor BB (PDGF-BB) for both epithelial and stromal CFU, and basic fibroblast growth factor (bFGF) for stromal, but not epithelial CFU. A sub-population of human endometrial stromal cells with mesenchymal stem cell properties of CFU activity and multilineage (fat, muscle, cartilage and bone) differentiation have been isolated by their co-expression of CD146 and PDGF-receptor beta. Candidate epithelial and stromal stem/progenitor cells have been identified in mouse endometrium as rare label retaining cells (LRCs) in the luminal epithelium and as perivascular cells at the endometrial-myometrial junction, respectively. While epithelial and most stromal LRC do not express estrogen receptor alpha (Esr1), they rapidly proliferate on estrogen stimulation, most likely mediated by neighbouring Esr1-expressing niche cells. It is likely that these newly identified endometrial stem/progenitor cells may play key roles in the development of gynecological diseases associated with abnormal endometrial proliferation such as endometriosis and endometrial cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0303-7207
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
288
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
22-9
|
pubmed:meshHeading |
pubmed-meshheading:18403104-Animals,
pubmed-meshheading:18403104-Endometrium,
pubmed-meshheading:18403104-Female,
pubmed-meshheading:18403104-Genital Diseases, Female,
pubmed-meshheading:18403104-Hormones,
pubmed-meshheading:18403104-Humans,
pubmed-meshheading:18403104-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:18403104-Signal Transduction,
pubmed-meshheading:18403104-Stem Cells
|
pubmed:year |
2008
|
pubmed:articleTitle |
Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells.
|
pubmed:affiliation |
Centre for Women's Health Research, Monash Institute of Medical Research, Monash University, Department of Obstetrics and Gynaecology, Monash Medical Centre, Clayton, Victoria Australia. Caroline.Gargett@med.monash.edu.au
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|